Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06776731

Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?

Led by Eastern Switzerland University of Applied Sciences · Updated on 2025-08-07

32

Participants Needed

1

Research Sites

133 weeks

Total Duration

On this page

Sponsors

E

Eastern Switzerland University of Applied Sciences

Lead Sponsor

U

University Hospital, Zürich

Collaborating Sponsor

AI-Summary

What this Trial Is About

Chronic obstructive pulmonary disease (COPD) is a global burden. Treatment options have improved in recent years, pulmonary rehabilitation plays a key role. Oxygen therapy is recommended in patients with a low saturation at rest, but no clear guidance is given for patients who desaturate during exercise. The effect of ambulatory oxygen during exercise is not yet completely understood, especially in those patients with exercise-induced desaturation. Aim: Evaluate the effect of supplemental oxygen therapy during a 3-months long ambulatory pulmonary rehabilitation program on exercise endurance. Patients will either receive supplemental oxygen therapy or room air during exercise training. Methods: A total of 32 patients with a confirmed diagnosis of COPD undergoing pulmonary rehabilitation will be included (male and female : aged ≥ 18 years; stable condition \&gt; 3 weeks (e.g. no exacerbations); resting oxygen saturation (SpO2) ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/ or below 90% during a 6-minute walking test). 3-months comprehensive PR for both intervention and control group including: education and awareness, instruction on inhalation therapies, smoking cessation counselling, respiratory and skeletal muscle training in groups, guided walks / cycle ergometer training. The intervention group will be trained using SSOT and the control group will receive sham air (ambient air). Patients and assessors will be blinded. Between group difference in cycling constant work rate exercise test (CWRET) time from baseline to 3 months SSOT (5l/min) vs ambient air will be the primary outcome of this study. Data will be summarized by means (SD) and medians (quartiles) for normal and non-normal distributions. Effects of treatment will be evaluated by mean differences with 95% confidence intervals, T-tests or Wilcoxon matched pair tests as appropriate. A p-value threshold of \<0.05 or a confidence interval not including zero will be considered as statistically significant. Analyses will be performed according to the intention to treat principle.

CONDITIONS

Official Title

Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female with confirmed COPD diagnosis (post-bronchodilator FEV1/FVC ratio <0.7 and over 10 pack-years smoking history)
  • Currently undergoing pulmonary rehabilitation
  • Aged 18 years or older
  • Stable condition for more than 3 weeks with no recent exacerbations
  • Resting oxygen saturation (SpO2) of 88% or higher
  • Exercise-induced hypoxemia defined by a drop in SpO2 by 4% or more and/or below 90% during a 6-minute walking test
  • Provided informed consent with signature
Not Eligible

You will not qualify if you...

  • Severe daytime resting hypoxemia with SpO2 below 88%
  • Receiving long-term oxygen therapy
  • Unstable health condition requiring changes in treatment or intensive care
  • Severe other diseases or conditions affecting participation
  • Inability to follow study procedures due to language, psychological, neurological, or orthopedic issues
  • Pregnant or breastfeeding women
  • Participation in another clinical trial with active treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kantonsspital Winterthur

Winterthur, Canton of Zurich, Switzerland, 8400

Actively Recruiting

Loading map...

Research Team

S

Stéphanie Saxer, PHD

CONTACT

S

Spencer Rezek

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter? | DecenTrialz